Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
4 February 2024
Salaheldin Ahmed, Abdulla Ahmed, Göran Rådegran
https://doi.org/10.1002/pul2.12340
Abstract
To the editor,
Pulmonary hypertension (PH) is a common condition, present in up to 10% in individuals aged >65 years.1 Whitin this entity, pulmonary arterial hypertension (PAH; group I PH) and chronic thromboembolic pulmonary hypertension (CTEPH; group 4 PH) comprise two rare, but detrimental conditions characterized by pulmonary vasculopathies and remodeling of pulmonary arteries, leading ultimately to right heart failure and death.2 These conditions are accompanied by high morbidity and mortality, for which early diagnosis and treatment initiation are paramount to improve outcome.3
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view